Skip to main content

Day: September 6, 2023

AGF Reports August 2023 Assets Under Management and Fee-Earning Assets

TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) — AGF Management Limited reported total assets under management (AUM) and fee-earning assets1 of $42.3 billion as at August 31, 2023.           AUM ($ billions) August 31, 2023 July 31, 2023 % ChangeMonth-Over-Month August 31, 2022 % Change Year-Over-YearTotal Mutual Fund (including retail pooled funds) $24.4 $24.5   $22.5  Institutional and Sub-advisory + Exchange-traded funds + AGF Private Wealth $15.8 $15.9   $15.0  Subtotal (before AGF Private Capital AUM and fee-earning assets1) $40.2 $40.4   $37.5  AGF Private Capital $0.1 $0.1   $0.1  Total AUM $40.3 $40.5 (0.5%) $37.6 7.2%AGF Private Capital fee-earning assets1 $2.0 $2.0   $2.0  Total AUM and fee-earning assets1 $42.3 $42.5 (0.5%) $39.6 6.8%           Average Daily Mutual Fund AUM $24.3 $24.3   $22.9  1 Fee-earning...

Continue reading

Olema Oncology to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Sept. 06, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will present at the following upcoming investor conferences in September:Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a Fireside Chat at the Morgan Stanley 21st Annual Global Healthcare Conference in New York on Monday, September 11, 2023, at 10:40 a.m. ET. Dr. Bohen will participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference in New York on Tuesday, September 12, 2023, at 10:30 a.m. ET. Dr. Bohen will participate in a Fireside Chat at the 2023 Cantor...

Continue reading

InterPrivate III Financial Partners Inc. Announces Extension of Deadline to Complete Initial Business Combination

New York, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) — InterPrivate III Financial Partners Inc. (NYSE American: IPVF.U, IPVF, IPVF WS) (the “Company”), announced today that its board of directors (the “Board”) has decided to extend the date by which the Company must consummate an initial business combination (the “Deadline Date”) from September 9, 2023 for an additional month, to October 9, 2023, the fourth of nine potential one-month extensions of the Deadline Date available to the Company. The Company’s Amended and Restated Certificate of Incorporation (the “Charter”) provides the Company the right to extend the Deadline Date up to nine times for an additional one month each time (each, an “Extension”), from June 9, 2023 to up to March 9, 2024. On August 31, 2023, pursuant to the Charter, the Board determined to implement a fourth...

Continue reading

Farmer Brothers announces transition of chief executive officer

Deverl Maserang to depart upon appointment of successor NORTHLAKE, Texas, Sept. 06, 2023 (GLOBE NEWSWIRE) — Farmer Brothers Company (NASDAQ: FARM), a leading roaster, wholesaler, equipment servicer and distributor of coffee, tea and other allied products, announced today it has commenced a transition of the chief executive officer role. Under the transition plan, the board of directors and Chief Executive Officer Deverl Maserang have mutually agreed his employment with Farmer Brothers will conclude on Sept. 30 and he will complete his current term as a member of the board, unless his permanent successor is identified prior to the end of his term. Farmer Brothers’ current Head of Coffee John Moore will assume the role of interim CEO starting Oct. 1. The planned transition is not connected to any disagreements or concerns with the...

Continue reading

Savaria Corporation announces $55 million public equity offering and $25 million concurrent private placement from CDPQ

Not for dissemination in the United States or through any wire service in the United States LAVAL, Québec, Sept. 06, 2023 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria” or the “Corporation”) (TSX: SIS), a global leader in the accessibility industry, is pleased to announce the issue and sale of common shares (“Common Shares”) pursuant to a public offering (the “Offering”) and a concurrent private placement (the “Concurrent Private Placement”, and collectively with the Offering, the “Equity Offerings”) for aggregate gross proceeds to the Corporation of approximately $80,025,500. Under the Offering, Savaria has entered into an agreement with a syndicate of underwriters led by National Bank Financial Inc., (the “Bookrunner”) and co-led by Desjardins Securities Inc., Scotiabank and TD Securities Inc. (collectively, the “Underwriters”)...

Continue reading

Peyto Announces Strategic Acquisition and Concurrent Bought Deal Offering

Complementary Acquisition FootprintComplementary Acquisition FootprintNOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Sept. 06, 2023 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (“Peyto” or the “Company”) (TSX: PEY) is pleased to announce it has entered into a partnership interest purchase agreement to acquire Repsol Canada Energy Partnership, which holds the Canadian upstream oil and gas business of Repsol Exploración, S.A.U., including all related midstream facilities and infrastructure located predominantly in the Deep Basin (collectively the “Assets”), for cash consideration of US$468 million (CDN$636 million) (“the Acquisition”) subject to closing adjustments. The Acquisition is expected to...

Continue reading

Acorn Hosts Annual Stockholder Meeting and Management Q&A in Person and via Zoom on Tuesday, September 12th at 1pm ET

BALTIMORE and WILMINGTON, Del., Sept. 06, 2023 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control solutions for stand-by power generators, gas pipelines, air compressors and other critical industrial assets, will hold its 2023 Annual Meeting of Stockholders at 1:00 PM ET on Tuesday, September 12, 2023 at 2800 Quarry Lake Drive, Suite 130, Baltimore, Maryland 21209. The meeting will also be accessible via Zoom for investors who register in advance by contacting Acorn’s Assistant Secretary by email at AcornMeeting@gmail.com. Annual Meeting Zoom Link: https://us02web.zoom.us/j/84545768072Telephone number: 1-646-558-8656 Meeting ID: 845 4576 8072 Registered participants will be admitted from the Zoom waiting room into the meeting at approximately 12:55 PM ET. On the day of the meeting,...

Continue reading

Gryphon Investors-Backed Meazure Learning Acquires Examity from Great Hill Partners

Online Proctoring Solutions Company Expands Meazure’s Operations, Technologies, and Services SAN FRANCISCO, Sept. 06, 2023 (GLOBE NEWSWIRE) — Meazure Learning, a leading full-service provider of test development and delivery solutions for higher education and professional testing, announced today it has acquired Examity, a leader in online proctoring for educators, certifying bodies, employers, and other assessment providers, from Great Hill Partners. Meazure Learning is a portfolio company of middle-market private equity firm Gryphon Investors. Great Hill will retain a minority position in Meazure moving forward, joining Gryphon, Eastside Partners, and members of the management team as stakeholders in the combined entity. Financial terms of the transaction were not disclosed. Founded in 2013, Examity partners with hundreds of...

Continue reading

Hyloris Pharmaceuticals Reports 2023 Half-Year Results and provides Business Outlook

Total revenue and other income nearly doubled (€2,4 million, +95%) R&D progress across the board, including initiation of the 4-arm Phase 2 clinical trial for AlenuraTM, targeting IC/BPS, a condition affecting at least 6 million U.S. patients PDUFA goal date for Maxigesic® IV set for 17 October 2023 by the U.S. FDA1 Evaluating external product candidates & advancing internal projects to reach 30 key assets before 2025 Multiple NDA2 submissions expected within the next 18 months Analyzing different go-to-market strategies for commercial launch of a range of cardiovascular product candidates in the U.S. healthcare market Net cash position of €39,2 million, sufficiently capitalized for all expected R&D expenditures related to the current product candidates3Webcast 7 September at 3PM CET / 2PM GMT / 10AM EST (register here) Liège,...

Continue reading

United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office

Asserts ‘793 patent in new litigation filed under Hatch-Waxman Act in response to Liquidia’s amendment to its NDA to add PH-ILD to YUTREPIA™ label Litigation is tied to same ‘793 patent previously ruled invalid by Patent Trial and Appeal Board (PTAB)MORRISVILLE, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company), announced today that United Therapeutics Corporation (UTHR) filed a patent infringement action under the Hatch-Waxman Act in the U.S. District Court for the District of Delaware (District Court) asserting infringement of U.S. patent No. 10,716,793 (‘793 patent) in response to Liquidia’s amendment to add the PH-ILD indication to the tentatively approved New Drug Application (NDA) for YUTREPIA™ (treprostinil) inhalation powder. The ‘793 patent was previously...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.